Literature DB >> 10196322

Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.

S M Lonning1, W Zhang, T C McGuire.   

Abstract

Antigen-specific T-helper (Th) lymphocytes are critical for the development of antiviral humoral responses and the expansion of cytotoxic T lymphocytes (CTL). Identification of relevant Th lymphocyte epitopes remains an important step in the development of an efficacious subunit peptide vaccine against equine infectious anemia virus (EIAV), a naturally occurring lentivirus of horses. This study describes Th lymphocyte reactivity in EIAV carrier horses to two proteins, p26 and p15, encoded by the relatively conserved EIAV gag gene. Using partially overlapping peptides, multideterminant and possibly promiscuous epitopes were identified within p26. One peptide was identified which reacted with peripheral blood mononuclear cells (PBMC) from all five EIAV-infected horses, and three other peptides were identified which reacted with PBMC from four of five EIAV-infected horses. Four additional peptides containing both CTL and Th lymphocyte epitopes were also identified. Multiple epitopes were recognized in a region corresponding to the major homology region of the human immunodeficiency virus, a region with significant sequence similarity to other lentiviruses including simian immunodeficiency virus, puma lentivirus, feline immunodeficiency virus, Jembrana disease virus, visna virus, and caprine arthritis encephalitis virus. PBMC reactivity to p15 peptides from EIAV carrier horses also occurred. Multiple p15 peptides were shown to be reactive, but not all infected horses had Th lymphocytes recognizing p15 epitopes. The identification of peptides reactive with PBMC from outbred horses, some of which encoded both CTL and Th lymphocyte epitopes, should contribute to the design of synthetic peptide or recombinant vector vaccines for EIAV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196322      PMCID: PMC104205     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.

Authors:  C D Partidos; P Vohra; M W Steward
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 2.  Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines.

Authors:  R C Montelaro; C Grund; M Raabe; B Woodson; R F Cook; S Cook; C J Issel
Journal:  AIDS Res Hum Retroviruses       Date:  1996-03-20       Impact factor: 2.205

3.  A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.

Authors:  L L An; J L Whitton
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets.

Authors:  G Stuhler; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences.

Authors:  G E Meister; C G Roberts; J A Berzofsky; A S De Groot
Journal:  Vaccine       Date:  1995-04       Impact factor: 3.641

6.  Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides.

Authors:  J P Sauzet; B Déprez; F Martinon; J G Guillet; H Gras-Masse; E Gomard
Journal:  Vaccine       Date:  1995-10       Impact factor: 3.641

7.  A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein.

Authors:  Y Nakamura; M Kameoka; M Tobiume; M Kaya; K Ohki; T Yamada; K Ikuta
Journal:  Vaccine       Date:  1997-04       Impact factor: 3.641

8.  Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.

Authors:  V Blazevic; A Ranki; K J Krohn
Journal:  AIDS Res Hum Retroviruses       Date:  1995-11       Impact factor: 2.205

9.  Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.

Authors:  M Shirai; M Chen; T Arichi; T Masaki; M Nishioka; M Newman; T Nakazawa; S M Feinstone; J A Berzofsky
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

10.  Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS.

Authors:  M Gerencer; I Valpotić; B Jukić; M Tomasković; I Basić
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

View more
  3 in total

1.  Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.

Authors:  Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

2.  Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2.

Authors:  Robert H Mealey; Matt H Littke; Steven R Leib; William C Davis; Travis C McGuire
Journal:  Vet Immunol Immunopathol       Date:  2007-04-08       Impact factor: 2.046

3.  Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.

Authors:  Chong Liu; Sheila J Cook; Jodi K Craigo; Frank R Cook; Charles J Issel; Ronald C Montelaro; David W Horohov
Journal:  Vet Immunol Immunopathol       Date:  2014-08-10       Impact factor: 2.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.